Filter News
Area of Research
News Topics
- (-) Biomedical (3)
- (-) ITER (1)
- (-) Molten Salt (2)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (1)
- Artificial Intelligence (4)
- Bioenergy (8)
- Biology (4)
- Buildings (2)
- Chemical Sciences (20)
- Climate Change (5)
- Composites (3)
- Computer Science (8)
- Coronavirus (2)
- Critical Materials (8)
- Cybersecurity (3)
- Decarbonization (4)
- Energy Storage (19)
- Environment (7)
- Exascale Computing (1)
- Frontier (2)
- Fusion (2)
- Grid (2)
- High-Performance Computing (2)
- Isotopes (5)
- Machine Learning (2)
- Materials (38)
- Materials Science (35)
- Microscopy (12)
- Nanotechnology (21)
- National Security (3)
- Net Zero (1)
- Neutron Science (18)
- Nuclear Energy (2)
- Partnerships (8)
- Physics (14)
- Polymers (6)
- Quantum Computing (1)
- Quantum Science (10)
- Renewable Energy (1)
- Security (1)
- Summit (1)
- Sustainable Energy (7)
- Transformational Challenge Reactor (1)
- Transportation (4)
Media Contacts
In a finding that helps elucidate how molten salts in advanced nuclear reactors might behave, scientists have shown how electrons interacting with the ions of the molten salt can form three states with different properties. Understanding these states can help predict the impact of radiation on the performance of salt-fueled reactors.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
ORNL's Larry Baylor and Andrew Lupini have been elected fellows of the American Physical Society.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.